I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital anomaly. It occurs in approximately 1/300,000 live births and represents 0.5% of all congenital heart disease cases.\[[@ref1]\] The majority of ALCAPA cases usually present in early infancy. With the decrease in pulmonary vascular resistance during the first few weeks of life, myocardial ischemia and/or infarction may occur. ALCAPA causes severe myocardial ischemia, global left ventricular (LV) dysfunction, and annular dilatation, producing various degrees of mitral regurgitation (MR). Patients with ALCAPA may present with congestive heart failure or cardiogenic shock. The clinical features depend on the degree of coronary artery collateral development.\[[@ref2]\] Due to the lack of specificity in its clinical manifestations, ALCAPA might be misdiagnosed as dilated cardiomyopathy, endocardial fibroelastosis, or mitral valve lesions.\[[@ref3]\] The early mortality rate can be as high as 90% if ALCAPA is not diagnosed and treated in a timely manner.\[[@ref1]\]

Coronary re-implantation is performed to establish a dual coronary system. However, systematic assessments of the LV function and size, MR, and complications of patients with ALCAPA managed with left coronary artery (LCA) re-implantation are limited.\[[@ref4]\] Although coronary computed tomography angiography, magnetic resonance imaging (MRI), and invasive angiocardiography are used for the diagnosis of ALCAPA, echocardiography still is harmless and inexpensive and is the most frequently used method at present. A retrospective analysis was conducted to elucidate the surgical outcomes of ALCAPA in infants and children using follow-up echocardiography.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Ethical approval {#sec2-1}
----------------

We presented our study to the Human Research Ethics Committee at Children\'s Hospital of Fudan University. Since it was a retrospective study and data analysis was performed anonymously, this study was exempt from ethical approval and the need to obtain informed consent from patients.

Patient population {#sec2-2}
------------------

Between September 2008 and March 2017, 26 children (9 males and 17 female), aged 45 days to 13.4 years with a median of 4.9 months, underwent repair of ALCAPA at Children\'s Hospital of Fudan University. Patient characteristics are summarized in [Table 1](#T1){ref-type="table"}. All the patients underwent direct LCA re-implantation.

###### 

Characteristics of the patients with ALCAPA

  Number   Age (months)/gender   Weight (kg)   LCA origin from PA                 Preoperative *Z*-score of LVEDD   Preoperative MVR   Preoperative LVEF (%)   Concomitant anomalies   Other information
  -------- --------------------- ------------- ---------------------------------- --------------------------------- ------------------ ----------------------- ----------------------- ----------------------------
  1        1.5/male              5.0           Right posterior near bifurcation   3.52                              Moderate           58                      PFO                     ECMO
  2        1.7/female            4.3           Left posterior                     3.80                              Mild               48                      PFO                     Serial echo follow-up
  3        2.0/male              4.6           Right posterior                    5.55                              Mild               50                      N                       Serial echo follow-up
  4        3.0/male              5.0           Left-facing sinus                  5.60                              Moderate           27                      PFO                     ECMO Serial echo follow-up
  5        3.2/male              4.8           Right pulmonary artery             3.39                              Mild               42                      CoA                     Serial echo follow-up
  6        3.5/female            5.0           Left posterior                     7.12                              Severe             30                      N                       Serial echo follow-up
  7        4.0/female            5.8           Right posterior near bifurcation   6.65                              Moderate           48                      N                       Serial echo follow-up
  8        4.0/male              4.7           Right posterior                    6.00                              Moderate           45                      PFO                     Early dead
  9        4.0/male              6.0           Right posterior                    3.54                              Moderate           51                      N                       Early dead
  10       4.1/female            6.0           Right posterior                    6.08                              Moderate           28                      N                       Lately dead
  11       4.2/male              6.0           Right posterior                    6.62                              Severe             38                      PFO                     Serial echo follow-up
  12       4.5/female            5.0           Left posterior                     7.70                              Severe             38                      PFO                     Serial echo follow-up
  13       4.8/female            5.5           Left posterior                     6.87                              Mild               35                      PDA                     Serial echo follow-up
  14       5.0/female            6.0           Left posterior                     5.21                              Moderate           41                      PFO                     Serial echo follow-up
  15       5.5/female            5.0           Right posterior                    6.40                              Mild               41                      PFO                     Serial echo follow-up
  16       8.0/female            7.0           Right posterior near bifurcation   0.55                              Moderate           64                      N                       Serial echo follow-up
  17       12.0/female           8.9           Right-facing sinus                 3.67                              Severe             55                      MVP                     Serial echo follow-up
  18       14.0/female           7.6           Right posterior near bifurcation   2.84                              Mild               40                      PDA                     Serial echo follow-up
  19       15.0/female           8.9           Right posterior                    5.25                              Moderate           34                      N                       Serial echo follow-up
  20       21.0/female           10.0          Right-facing sinus                 3.74                              Moderate           67                      MVP                     Serial echo follow-up
  21       29.0/male             14.0          Right posterior                    4.15                              Severe             60                      N                       Serial echo follow-up
  22       46.0/male             16.0          Left posterior                     2.52                              Moderate           58                      N                       Serial echo follow-up
  23       60.0/female           16.0          Posterior                          4.67                              Moderate           43                      N                       Serial echo follow-up
  24       92.0/female           23.0          Left-facing sinus                  −0.62                             Mild               66                      N                       Echo follow-up
  25       117.0/female          28.0          Left-facing sinus                  1.43                              Moderate           67                      N                       Echo follow-up
  26       161.0/female          39.0          Right posterior                    2.65                              Moderate           69                      N                       Echo follow-up

ECMO: Extracorporeal membrane oxygenation; LCA: Left coronary artery; LVEF: Left ventricular ejection fraction; LVEDD: Left ventricular end-diastolic diameter; MVR: Mitral valve regurgitation; PA: Pulmonary artery; PFO: Patent foramen ovale; MVP: Mitral valve prolapse; ALCAPA: Anomalous left coronary artery from the pulmonary artery; CoA: Coarctation of the aorta; PDA: Patent ductus arteriosus; N: Without other concomitant anomaly.

Follow-up echocardiography {#sec2-3}
--------------------------

Transthoracic echocardiography was performed using an IE33 echocardiography system (Philips Medical Systems, USA) or Vivid7 echocardiography system (General Electric Company, USA). We focused on the end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction of the left ventricle (LVEF), and the degree of MR. Routine two-dimensional parasternal long-axis and parasternal short-axis imaging were used to evaluate the EDV, ESV, SV, and LVEF. The severity of MR was graded using conventional guidelines.\[[@ref5]\] The parasternal aorta short-axis view was estimated to obtain the origin and course of the LCA using cross-sectional imaging. Color Doppler flow imaging was used to observe the distribution of blood flow, especially after LCA re-implantation.

Statistical analysis {#sec2-4}
--------------------

Data were analyzed using SPSS software (version 17.0; SPSS, Inc., Chicago, IL, USA). Descriptive statistics for continuous data were expressed as mean ± standard deviation, whereas skewed continuous data were expressed as median (range). Categorical data were summarized as frequencies and percentages. Statistically significant differences were indicated when *P* \< 0.05.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

From September 2008 to March 2017, 26 children diagnosed with ALCAPA underwent LCA re-implantation. The patients were diagnosed with ALCAPA at a median age of 4.5 months (range: 43 days -- 13 years). The main clinical manifestations were respiratory tract infection, heart failure, dyspnea, feeding intolerance, and failure to thrive. The median age at operation was 4.9 months (range: 45 days -- 13 years). Sixteen (61.5%) patients were \<1 year old. The median weight at operation was 6.0 kg (range, 4.3--39.0 kg).

Early mortality was defined as death within 30 days of the operation. All other deaths were considered late mortality. The early mortality rate was 7.7% (2 of 26 patients) because of congestive cardiac failure and arrhythmia. The late mortality rate was 3.8% (1 of 26 patients, a girl who underwent surgery at 4 months of age and died 5 months after the operation because of persistent LV dysfunction).

All the other surviving patients (23 of 26 patients \[88.4%\]) received echocardiographic during follow-up (median follow-up of 32 months; range: 3 months to 8 years). Two infants (one aged 1.5 months and the other aged 3.0 months) required extracorporeal membrane oxygenation (ECMO) after the operation. One 1.5-month-old infant was operated in March 2017. Nineteen patients (73.1%) underwent serial postoperative echocardiography during follow-up (median follow-up of 40 months; range: 3 months to 8 years). Serial postoperative echocardiography was performed after the operation (on the 1^st^ day, the 3^rd^ day, the 7^th^ day, the 14^th^ day, the 1^st^ month, the 3^rd^ month, the 6^th^ month, and so on until LV function was normal and then performed once every year).

Left ventricular function and size {#sec2-5}
----------------------------------

Before repair, twenty patients (76.9%) presented with LV dysfunction. The median preoperative LVEF was 46% (range: 27--69%). Seven patients (26.9%) had a preoperative LVEF \<40%. The mean *Z*-score for the preoperative LV end-diastolic diameter was 4.42 ± 2.09. Twenty-four patients (92.3%) presented with endocardial fibroelastosis on echocardiography. Aneurysm formation was present in one patient (3.8%).

Twenty-three patients received the echocardiography during follow-up. The mean LVEF after operation in these patients was 66.0 ± 7.0% (compared with a mean preoperative LVEF of 48.0 ± 12.9%; *P* = 0.000). The mean *Z*-score for the postoperative LV end-diastolic diameter was 1.28 ± 1.08 (compared with a mean preoperative *Z*-score of 4.18 ± 2.11, *P* = 0.000). The echocardiography studies demonstrated an improvement in LV function in all the surviving children. Serial postoperative echocardiograms were available for 19 patients. Five patients (26.3%) presented with normal LVEF before the operation. In the other 14 patients, LV function normalized at a median time of 5.3 months (range: 0.5--36.0 months). The *Z*-score for LV end-diastolic diameter also decreased within the same period. However, two patients who presented with severe myocardial dysfunction (LVEF was 34% and 38%, respectively) upon diagnosis still displayed abnormal features, such as echo-dense papillary muscles and endocardium, despite normal LVEF.

Degree of mitral regurgitation {#sec2-6}
------------------------------

MR was present in all patients before the operation: it was mild in 7 patients (26.9%), moderate in 14 patients (53.9%), and severe in 5 patients (19.2%). Two patients (7.7%) underwent mitral valve repair at the time of ALCAPA repair (both had mitral valve prolapse). After the operation, none of these patients required additional mitral valve repair. MR was reduced in all patients \[[Table 2](#T2){ref-type="table"}\]. At the most recent follow-up, 4 patients were free of MR and 15 patients had mild MR.

###### 

Surgical outcomes of ALCAPA by follow-up echocardiography

  Patient number   Age (months)   Serial echo follow-up   Mitral valve repair   LV function normalized time (months)   Preoperation   Postoperation                           
  ---------------- -------------- ----------------------- --------------------- -------------------------------------- -------------- --------------- ---------- ---- ------- ----------
  1                1.5            Y                       N                     2.0                                    58             3.52            Moderate   60   0.59    Mild
  2                1.7            Y                       N                     0.5                                    48             3.80            Mild       71   1.48    Free
  3                2.0            Y                       N                     1.0                                    50             5.55            Mild       68   0.99    Mild
  4                3.0            N                       N                     /                                      27             5.60            Moderate   66   0.21    Mild
  5                3.2            Y                       N                     0.5                                    42             3.39            Mild       61   2.30    Free
  6                3.5            Y                       N                     7.0                                    30             7.12            Severe     69   1.95    Moderate
  7                4.0            Y                       N                     8.0                                    48             3.54            Moderate   71   −0.85   Free
  8                4.2            Y                       N                     4.5                                    38             6.62            Severe     72   0.60    Mild
  9                4.5            Y                       N                     5.5                                    38             7.70            Severe     71   1.90    Moderate
  10               4.8            N                       N                     /                                      35             6.87            Mild       43   4.15    Mild
  11               5.0            Y                       N                     13.0                                   41             5.21            Moderate   63   1.23    Moderate
  12               5.5            Y                       N                     6.0                                    41             6.40            Mild       64   0.03    Mild
  13               8.0            Y                       N                     /                                      64             0.55            Moderate   74   1.76    Free
  14               12             Y                       Y                     16.0                                   55             3.67            Severe     65   1.64    Moderate
  15               14             Y                       N                     5.0                                    40             2.84            Mild       63   1.83    Mild
  16               15             Y                       N                     36.0                                   34             5.25            Moderate   62   1.76    Mild
  17               21             Y                       Y                     /                                      67             3.74            Moderate   75   2.40    Mild
  18               29             N                       N                     /                                      60             4.15            Severe     74   1.50    Moderate
  19               46             N                       N                     /                                      58             2.57            Moderate   68   1.87    Mild
  20               60             Y                       N                     3.0                                    43             4.67            Moderate   66   1.72    Mild
  21               92             Y                       N                     /                                      66             −0.62           Mild       72   −0.62   Free
  22               117            Y                       N                     /                                      67             1.43            Moderate   60   0.35    Mild
  23               161            Y                       N                     /                                      69             2.65            Moderate   61   0.68    Mild

LVEF: Left ventricular ejection fraction; LVEDD: Left ventricular end-diastolic diameter; MR: Mitral regurgitation; LV: Left ventricular; ALCAPA: Anomalous left coronary artery from the pulmonary artery; Y: Yes; N: No; /: Not available.

Patency of the left coronary artery {#sec2-7}
-----------------------------------

Since there was no sign of coronary obstruction in any of the surviving patients, no routine coronary angiography was performed after the operation. We used the parasternal aorta short-axis view to obtain the origin and course of the LCA with cross-sectional imaging. Color Doppler flow imaging was used to observe the distribution of blood flow, especially the LCA blood flow after the operation. All the surviving patients had patency of the proximal LCA that was confirmed by echocardiography at the most recent follow-up.

Complications {#sec2-8}
-------------

Supravalvar pulmonary stenosis and right pulmonary stenosis have been described as complications of the surgical approach. Six of the surviving patients (26.1%) showed supravalvar pulmonary stenosis and seven patients (30.4%) showed right pulmonary stenosis during the follow-up. The follow-up echocardiography showed a systolic infundibular dynamic gradient of 13.0--40.7 mmHg. None of the patients presented signs of aortic valve incompetence at the long-term echocardiography follow-up.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Echocardiography is an important non-invasive auxiliary examination for diagnosing and functionally evaluating suspected congenital heart disease, including ALCAPA, in infants and children.\[[@ref6][@ref7]\] In addition, it serves as an important imaging tool for assessing outcomes after operation. After the ALCAPA operation, echocardiography can confirm the prograde flow from the aorta into the LCA. It can also follow the recovery of the LV function and the improvement of MR.

In many centers, direct re-implantation of the LCA into the aorta include coronary button transfer that had been proven successful and is considered the standard surgical strategy.\[[@ref8][@ref9][@ref10]\] The operation is performed to establish a dual coronary system. All patients had undergone LCA re-implantation to the aorta at our center. Our results confirmed the findings of other centers that building a dual coronary system with direct LCA re-implantation is the preferred method for managing ALCAPA.

The postoperative course was variable. Despite the establishment of a dual coronary system, some patients may experience extensive irreversible LV myocardial damage and present constant LV dysfunction. However, the surgical outcomes of most patients are encouraging. Naimo *et al*.\[[@ref4]\] summarized the mortality from previous studies and concluded that early mortality in patients with ALCAPA was 0--16% in some centers; late mortality was rare, and survival rates of 86--100% at 10 years have been reported. In our research, the early mortality rate was 7.7%, and the late mortality rate was 3.8%.

Preoperative LV dysfunction and/or more severe preoperative MR were reported as incremental risk factors for postoperative mortality.\[[@ref11]\] In some centers, earlier age might also have been related to mortality, probably because of inadequate coronary collateral development or more severe ventricular ischemia or dysfunction or both.\[[@ref12]\] However, in our study, the preoperative LVEF, degree of preoperative MR, and age at operation were not seemed to be significant risk factors for mortality outcomes. Caspi *et al*.\[[@ref13]\] reported that increased support with a positive inotropic agent and/or ECMO might be required in younger patients. We had a similar outcome, probably because those patients had less hibernating myocardium and less development of coronary collaterals than that of older patients.\[[@ref13][@ref14]\]

Mid- and long-term LV function and clinical status improved over time. Some patients, especially younger ones and those with severe LV dysfunction, might require a period of LV support to allow the recovery of both stunned and hibernating myocardia. Serial postoperative echocardiography during follow-up showed complete recovery of LV function in all the surviving patients in our study. In patients whose preoperative LVEF \<40%, LV function normalized at a median time of 6.3 months (range: 4.5 to 36.0 months). Our study demonstrated that, in 78.6% of patients (11 out of 14 patients), the normalization of LVEF and LV functional factors occurred within one year after the operation. LVEF and LV dilatation improved over the ensuing 2--3 months, probably reflecting the recruitment of hibernating or chronically ischemic myocardium. In patients whose preoperative LVEF ≥40%, the median normalized time was 4.0 months (range: 0.5 - 16.0 months). It appeared that patients with lower preoperative LVEF required more time for normalization. However, the number of patients in our study was small, and consequently, we could not perform statistical comparisons. Patients whose preoperative LVEF was normal tended to have normal LV function quickly after the operation, possibly because they had developed a rich collateral system between two coronary arteries that could ameliorate myocardial ischemia. However, they also needed time to achieve a normalized LV end-diastolic diameter. Patients who presented with severe myocardial dysfunction before the operation still displayed abnormal features, such as echo-dense papillary muscles or endocardium, in the most recent echocardiography follow-up. However, standard echocardiography might be less than perfect in some ways, such as detecting scars and perfusion deficits in the LV. In those patients, especially older children, lifelong surveillance with MRI and myocardial perfusion imaging might be needed to detect and evaluate dysfunction.\[[@ref14]\]

Due to LV dilatation and ischemic cardiomyopathy, MR is considered a coexistent manifestation in most patients with ALCAPA.\[[@ref15]\] In some patients, MR might be the only indication suggesting ALCAPA. Whether to repair the mitral valve at the same time as the LCA re-implantation remains controversial. Several studies have reported that simultaneous mitral valve repair had no effect on the normalization of LV function or other surgical outcomes, although the degree of MR might improve after the operation. These studies did not advocate addressing the mitral valve at the same time as the ALCAPA repair, regardless of MR severity.\[[@ref14][@ref15][@ref16][@ref17]\] Other researchers have suggested that mitral valve repair is needed only when the valve is structurally defective.\[[@ref18]\] In our study, MR was present in all patients before the operation. Nineteen patients had preoperative moderate or severe MR, and only two patients underwent mitral valve repair during the ALCAPA repair because of the mitral valve structural problem (both patients had mitral valve prolapse). Echocardiography is a vital tool for evaluating the degree of MR. With follow-up echocardiography, especially serial postoperative follow-up echocardiography, we could observe the changes in the MR after the operation. In the two patients with a structurally defective mitral valve, MR was reduced after the operation. During our follow-up period (4--5 years), these patients did not need further mitral valve operation. In other patients, including three with severe MR, the degree of MR decreased as the LV function improved. MR tended to improve postoperatively once a dual coronary system was restored. This could be the result of the decrease in mitral annular diameter with the reduction in LV dimensions and improved perfusion of the myocardium (particularly the papillary muscle). No patient in our series required late mitral valve replacement. In the majority of patients with ALCAPA seen at our center, both LV function and MR normalized over time. Improvements in MR suggested ischemic recovery, which might lag behind the normalization of LV function. Therefore, intervention in patients without structurally defective mitral valve did not seem necessary.

The high rate of late LCA patency after direct implantation was proven.\[[@ref19]\] Echocardiography could determine the patency of the proximal LCA. We used the parasternal aorta short-axis view with cross-sectional imaging to obtain the origin and course of the LCA and the blood flow after the operation. However, echocardiography had some difficulty in displaying the distal coronary artery. Therefore, we also needed to focus on other features, such as LV function and MR. Postoperative coronary stenosis should be suspected in a patient with persistent LV dysfunction. Worsening MR also reflected the patency of the LCA. Coronary stenosis might also exist when MR recurs or persists for a long time. Cardiac catheterization should be performed to assess the patency of the LCA before performing additional mitral valve surgery.\[[@ref11]\] Standard electrocardiography and MRI were also suggestive. If serious coronary stenosis exists, patch angioplasty should be performed.\[[@ref16][@ref20]\] No patient at our center required reoperation for coronary stenosis. All surviving patients were asymptomatic after the operation. Standard electrocardiography revealed no arrhythmias or ischemic change, such as T-wave change, in any of the investigated patients. No routine coronary angiography was performed. Postoperative echocardiograms demonstrated a patent LCA in all patients. All surviving patients had patency of the proximal LCA confirmed with echocardiography at the most recent follow-up.

Supravalvular pulmonary stenosis is a late complication of surgery for anomalous coronary origin.\[[@ref21]\] Supravalvar pulmonary stenosis and right pulmonary artery stenosis had been described as a result of pulmonary artery reconstruction. In our research, no patient required an additional operation because of this complication.

Since the incidence rate of ALCAPA is low and our study was a single-center study, the number of patients and outcomes were small. For this reason, statistical analysis was limited (statistical comparisons and a descriptive study could not be performed). This study also had the limitations of a retrospective study. Additional studies are necessary in the future.

In conclusion, this study provides insight into the correlation between echocardiography changes (such as LV function, MR, and surgical complications) and the surgical outcomes of ALCAPA over time. Our study appeared to be consistent with previous studies in terms of mortality, recovery of the LV function, and improvement of MR. Coronary re-implantation was effective for rebuilding a dual coronary system in patients with ALCAPA and resulted in the progressive improvement of LV function. MR tended to improve without structural defects of the mitral valve. Echocardiography is valuable for evaluating the therapeutic effect of coronary re-implantation.
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